Study guide

8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

NPLEX Part I — Biomedical Sciences Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Pacing, and GEA Strategy

1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards

2 Chapter 2: Gross Anatomy & Musculoskeletal System

2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures

3 Chapter 3: Histology & Microscopic Anatomy

3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium

4 Chapter 4: Neuroanatomy & Special Senses

4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation

5 Chapter 5: Embryology & Developmental Anatomy

5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology

6 Chapter 6: Cellular & General Physiology

6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle

7 Chapter 7: Cardiovascular & Respiratory Physiology

7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing

8 Chapter 8: Renal, Fluid, & Acid-Base Physiology

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology

9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation

10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism

10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport

11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics

11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics

12 Chapter 12: Immunology & Immunopathology

12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types

13 Chapter 13: Medical Microbiology

13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens

14 Chapter 14: General Pathology & Neoplasia

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors

15 Chapter 15: Systems Pathology & Disease Mechanisms

15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract

8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

Key Takeaways Explain This Topic AI

Blood pH is governed by the Henderson-Hasselbalch equation: pH = 6.1 + log([HCO3-] / (0.03 * PCO2)); arterial blood gas physiological targets are pH 7.35–7.45, PCO2 35–45 mmHg, and HCO3- 22–26 mEq/L.

Metabolic acidosis is characterized by primary reduction in [HCO3-], compensated by hyperventilation evaluated via Winter's formula: Expected PCO2 = (1.5 * [HCO3-]) + 8 +/- 2.

Serum anion gap (AG = Na+ - (Cl- + HCO3-), normal 8–12 mEq/L) differentiates high anion gap metabolic acidosis (MUDPILES / GOLDMARK causes) from normal anion gap hyperchloremic acidosis (diarrhea, RTAs).

Metabolic alkalosis involves primary elevation in [HCO3-], with compensation via hypoventilation, categorized by urinary chloride into saline-responsive (<20 mEq/L) and saline-resistant (>20 mEq/L) etiologies.

Respiratory acid-base disorders stem from primary PCO2 alterations, invoking biphasic renal compensation: acute responses occur within hours via tubular transport shifts, while chronic responses require 3–5 days for full upregulation of renal H+ secretion and HCO3- reabsorption.

Last updated: July 2026

Loading diagram... Systemic Acid-Base Diagnostic Workup

8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

Acid-base homeostasis maintains arterial blood pH within a narrow physiological range of 7.35 – 7.45 7.35–7.45 7.35–7.45 ( [ H + ] ≈ 35 – 45 nmol/L [\text{H}^+] \approx 35–45\text{ nmol/L} [ H + ] ≈ 35–45 nmol/L ). Precise pH control is required to prevent protein denaturation and preserve enzyme kinetics. Acid-base stability relies on instantaneous chemical buffering, rapid respiratory response, and definitive renal excretion of non-volatile acids.

Henderson-Hasselbalch Kinetics and Reference Values

The primary extracellular buffer is the bicarbonate-carbonic acid buffer system : CO 2 + H 2 O ↔ Carbonic Anhydrase H 2 CO 3 ↔ H + + HCO 3 − \text{CO}_2 + \text{H}_2\text{O} \xleftrightarrow{\text{Carbonic Anhydrase}} \text{H}_2\text{CO}_3 \xleftrightarrow{} \text{H}^+ + \text{HCO}_3^- CO 2 ​ + H 2 ​ O Carbonic Anhydrase ​ H 2 ​ CO 3 ​ ​ H + + HCO 3 − ​

The Henderson-Hasselbalch Equation

Systemic pH is mathematically defined by the Henderson-Hasselbalch equation: pH = pK a + log ⁡ ( [ HCO 3 − ] [ H 2 CO 3 ] ) = 6.1 + log ⁡ ( [ HCO 3 − ] 0.03 ⋅ P CO 2 ) \text{pH} = \text{pK}_a + \log \left( \frac{[\text{HCO}_3^-]}{[\text{H}_2\text{CO}_3]} \right) = 6.1 + \log \left( \frac{[\text{HCO}_3^-]}{0.03 \cdot P_{\text{CO}_2}} \right) pH = pK a ​ + lo g ( [ H 2 ​ CO 3 ​ ] [ HCO 3 − ​ ] ​ ) = 6.1 + lo g ( 0.03 ⋅ P CO 2 ​ ​ [ HCO 3 − ​ ] ​ )

Where 0.03 0.03 0.03 is the solubility coefficient of CO 2 \text{CO}_2 CO 2 ​ in blood ( mmol/L per mmHg \text{mmol/L per mmHg} mmol/L per mmHg ), P CO 2 P_{\text{CO}_2} P CO 2 ​ ​ reflects respiratory control, and [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] reflects renal metabolic control.

  • Normal Arterial Blood Gas (ABG) Reference Ranges
  • pH : 7.35 – 7.45 7.35 – 7.45 7.35–7.45 (Acidemia < 7.35 < 7.35 < 7.35 ; Alkalemia > 7.45 > 7.45 > 7.45 )

P CO 2 P_{\text{CO}_2} P CO 2 ​ ​ : 35 – 45 mmHg 35 – 45\text{ mmHg} 35–45 mmHg (Primary respiratory component)

[ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] : 22 – 26 mEq/L 22 – 26\text{ mEq/L} 22–26 mEq/L (Primary metabolic component)

Primary Acid-Base Disturbances and Compensatory Rules

When a primary disturbance alters pH, the opposing system initiates compensatory responses to return the [ HCO 3 − ] / P CO 2 [\text{HCO}_3^-] / P_{\text{CO}_2} [ HCO 3 − ​ ] / P CO 2 ​ ​ ratio toward normal. Compensation never fully overcorrects arterial pH back to 7.40 7.40 7.40 .

Primary Disorder Initial Change Secondary Compensatory Response Formula for Expected Compensation

Metabolic Acidosis [ HCO 3 − ] ↓ [\text{HCO}_3^-] \downarrow [ HCO 3 − ​ ] ↓ P CO 2 ↓ P_{\text{CO}_2} \downarrow P CO 2 ​ ​ ↓ (Hyperventilation) Winter's Formula : Expected P CO 2 = ( 1.5 ⋅ [ HCO 3 − ] ) + 8 ± 2 \text{Expected } P_{\text{CO}_2} = (1.5 \cdot [\text{HCO}_3^-]) + 8 \pm 2 Expected P CO 2 ​ ​ = ( 1.5 ⋅ [ HCO 3 − ​ ]) + 8 ± 2

Metabolic Alkalosis [ HCO 3 − ] ↑ [\text{HCO}_3^-] \uparrow [ HCO 3 − ​ ] ↑ P CO 2 ↑ P_{\text{CO}_2} \uparrow P CO 2 ​ ​ ↑ (Hypoventilation) Expected P CO 2 = 40 + 0.7 ⋅ ( [ HCO 3 − ] − 24 ) ± 2 \text{Expected } P_{\text{CO}_2} = 40 + 0.7 \cdot ([\text{HCO}_3^-] - 24) \pm 2 Expected P CO 2 ​ ​ = 40 + 0.7 ⋅ ([ HCO 3 − ​ ] − 24 ) ± 2

Acute Respiratory Acidosis P CO 2 ↑ P_{\text{CO}_2} \uparrow P CO 2 ​ ​ ↑ [ HCO 3 − ] ↑ [\text{HCO}_3^-] \uparrow [ HCO 3 − ​ ] ↑ (Cellular buffering) [ HCO 3 − ] ↑ [\text{HCO}_3^-] \uparrow [ HCO 3 − ​ ] ↑ by 1 mEq/L 1\text{ mEq/L} 1 mEq/L per 10 mmHg ↑ P CO 2 10\text{ mmHg} \uparrow P_{\text{CO}_2} 10 mmHg ↑ P CO 2 ​ ​

Chronic Respiratory Acidosis P CO 2 ↑ P_{\text{CO}_2} \uparrow P CO 2 ​ ​ ↑ [ HCO 3 − ] ↑ [\text{HCO}_3^-] \uparrow [ HCO 3 − ​ ] ↑ (Renal synthesis) [ HCO 3 − ] ↑ [\text{HCO}_3^-] \uparrow [ HCO 3 − ​ ] ↑ by 3.5 – 4 mEq/L 3.5–4\text{ mEq/L} 3.5–4 mEq/L per 10 mmHg ↑ P CO 2 10\text{ mmHg} \uparrow P_{\text{CO}_2} 10 mmHg ↑ P CO 2 ​ ​

Acute Respiratory Alkalosis P CO 2 ↓ P_{\text{CO}_2} \downarrow P CO 2 ​ ​ ↓ [ HCO 3 − ] ↓ [\text{HCO}_3^-] \downarrow [ HCO 3 − ​ ] ↓ (Cellular buffering) [ HCO 3 − ] ↓ [\text{HCO}_3^-] \downarrow [ HCO 3 − ​ ] ↓ by 2 mEq/L 2\text{ mEq/L} 2 mEq/L per 10 mmHg ↓ P CO 2 10\text{ mmHg} \downarrow P_{\text{CO}_2} 10 mmHg ↓ P CO 2 ​ ​

Chronic Respiratory Alkalosis P CO 2 ↓ P_{\text{CO}_2} \downarrow P CO 2 ​ ​ ↓ [ HCO 3 − ] ↓ [\text{HCO}_3^-] \downarrow [ HCO 3 − ​ ] ↓ (Renal excretion) [ HCO 3 − ] ↓ [\text{HCO}_3^-] \downarrow [ HCO 3 − ​ ] ↓ by 5 mEq/L 5\text{ mEq/L} 5 mEq/L per 10 mmHg ↓ P CO 2 10\text{ mmHg} \downarrow P_{\text{CO}_2} 10 mmHg ↓ P CO 2 ​ ​

Metabolic Acidosis and Serum Anion Gap

Metabolic acidosis originates from primary reduction in [ HCO 3 − ] < 22 mEq/L [\text{HCO}_3^-] < 22\text{ mEq/L} [ HCO 3 − ​ ] < 22 mEq/L . Diagnostic evaluation begins by calculating the Serum Anion Gap (AG) : Anion Gap (AG) = [ Na + ] − ( [ Cl − ] + [ HCO 3 − ] ) ( Normal: 8 – 12 mEq/L ) \text{Anion Gap (AG)} = [\text{Na}^+] - \left( [\text{Cl}^-] + [\text{HCO}_3^-] \right) \quad (\text{Normal: } 8\text{--}12\text{ mEq/L}) Anion Gap (AG) = [ Na + ] − ( [ Cl − ] + [ HCO 3 − ​ ] ) ( Normal: 8 – 12 mEq/L )

Albumin Correction : Corrected AG = AG + 2.5 ⋅ ( 4.0 − Patient Albumin in g/dL ) \text{AG} = \text{AG} + 2.5 \cdot (4.0 - \text{Patient Albumin in g/dL}) AG = AG + 2.5 ⋅ ( 4.0 − Patient Albumin in g/dL ) . Metabolic Acidosis (pH < 7.35, HCO3- < 22)

  • ├── High Anion Gap (> 12 mEq/L): MUDPILES / GOLDMARK (Organic Acid Accumulation)
  • └── Normal Anion Gap (8-12 mEq/L): Hyperchloremic (Diarrhea, RTA Types 1, 2, 4)
  • 1. High Anion Gap Metabolic Acidosis (HAGMA)

Caused by accumulation of unmeasured organic anions that consume [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] without increasing [ Cl − ] [\text{Cl}^-] [ Cl − ] .

MUDPILES Mnemonic :

  • M ethanol (Formic acid)
  • U remia (Advanced renal failure)
  • D KA (Diabetic Ketoacidosis: β \beta β -hydroxybutyrate)
  • P ropylene glycol
  • I soniazid / Iron
  • L actic acidosis (L-lactate from tissue hypoperfusion)
  • E thylene glycol (Oxalic and glycolic acid)
  • S alicylates (Aspirin toxicity—produces mixed HAGMA and primary respiratory alkalosis)

GOLDMARK Mnemonic : Glycols, Oxoproline (acetaminophen overuse), L-lactate, D-lactate, Methanol, Aspirin, Renal failure, Ketoacidosis.

2. Normal Anion Gap Metabolic Acidosis (NAGMA / Hyperchloremic Acidosis)

Caused by direct loss of HCO 3 − \text{HCO}_3^- HCO 3 − ​ replaced reciprocally by Cl − \text{Cl}^- Cl − , preserving normal AG ( 8 – 12 mEq/L 8–12\text{ mEq/L} 8–12 mEq/L ).

Gastrointestinal Losses : Severe diarrhea, pancreatic fistula, ureterosigmoidostomy.

Renal Tubular Acidosis (RTA) :

Type 1 (Distal RTA) : Failure of α \alpha α -intercalated cells to secrete H + \text{H}^+ H + . Impaired urine acidification ( urine pH > 5.5 > 5.5 > 5.5 ). Causes hypokalemia, nephrolithiasis (calcium phosphate stones).

Type 2 (Proximal RTA) : Defective PCT HCO 3 − \text{HCO}_3^- HCO 3 − ​ reabsorption. Urine pH initial > 5.5 > 5.5 > 5.5 , later < 5.5 < 5.5 < 5.5 as filtered load drops. Associated with hypokalemia and Fanconi syndrome .

Type 4 (Hyperkalemic RTA) : Aldosterone deficiency or resistance. Decreased distal Na + \text{Na}^+ Na + reabsorption impairs H + \text{H}^+ H + and K + \text{K}^+ K + secretion. Causes hyperkalemia and urine pH < 5.5 < 5.5 < 5.5 .

Metabolic Alkalosis and Urinary Chloride Differentiation

Metabolic alkalosis ( [ HCO 3 − ] > 26 mEq/L [\text{HCO}_3^-] > 26\text{ mEq/L} [ HCO 3 − ​ ] > 26 mEq/L , pH > 7.45 \text{pH} > 7.45 pH > 7.45 ) is categorized by Urinary Chloride ( U Cl U_{\text{Cl}} U Cl ​ ) responsiveness:

1. Saline-Responsive ( U Cl < 20 mEq/L U_{\text{Cl}} < 20\text{ mEq/L} U Cl ​ < 20 mEq/L )

Mechanism : Volume depletion leads to ECF contraction, activating RAAS. Secondary hyperaldosterone increases distal H + \text{H}^+ H + secretion, while low luminal Cl − \text{Cl}^- Cl − impairs Pendrin HCO 3 − \text{HCO}_3^- HCO 3 − ​ secretion. Responds to 0.9 % 0.9\% 0.9% NaCl infusion.

Causes : Vomiting, nasogastric suction, loop or thiazide diuretic therapy (post-dosing phase), contraction alkalosis.

2. Saline-Resistant ( U Cl > 20 mEq/L U_{\text{Cl}} > 20\text{ mEq/L} U Cl ​ > 20 mEq/L )

Mechanism : Mineralocorticoid excess or profound hypokalemia directly drives distal H + \text{H}^+ H + secretion independent of volume. Unresponsive to saline resuscitation.

Causes : Primary Hyperaldosteronism (Conn syndrome), Cushing syndrome, Bartter / Gitelman syndromes, severe hypokalemia ( [ K + ] < 2.0 mEq/L [\text{K}^+] < 2.0\text{ mEq/L} [ K + ] < 2.0 mEq/L ).

Respiratory Acid-Base Disorders

Respiratory Acidosis ( P CO 2 > 45 mmHg P_{\text{CO}_2} > 45\text{ mmHg} P CO 2 ​ ​ > 45 mmHg , pH < 7.35 \text{pH} < 7.35 pH < 7.35 )

Etiologies : Hypoventilation from opioid overdose, COPD, acute severe asthma, neuromuscular paralysis (Guillain-Barré, ALS).

Biphasic Compensation : Acute compensation relies on intracellular protein buffering ( + 1 mEq/L HCO 3 − +1\text{ mEq/L } \text{HCO}_3^- + 1 mEq/L HCO 3 − ​ per 10 mmHg ↑ P CO 2 10\text{ mmHg} \uparrow P_{\text{CO}_2} 10 mmHg ↑ P CO 2 ​ ​ ). Chronic compensation (3–5 days) requires renal upregulation of H + \text{H}^+ H + -ATPase and ammoniagenesis ( + 3.5 – 4 mEq/L HCO 3 − +3.5–4\text{ mEq/L } \text{HCO}_3^- + 3.5–4 mEq/L HCO 3 − ​ per 10 mmHg ↑ P CO 2 10\text{ mmHg} \uparrow P_{\text{CO}_2} 10 mmHg ↑ P CO 2 ​ ​ ).

Respiratory Alkalosis ( P CO 2 < 35 mmHg P_{\text{CO}_2} < 35\text{ mmHg} P CO 2 ​ ​ < 35 mmHg , pH > 7.45 \text{pH} > 7.45 pH > 7.45 )

Etiologies : Hyperventilation from panic attacks, high-altitude hypoxia, pulmonary embolism, early salicylate toxicity, mechanical ventilation.

Biphasic Compensation : Acute compensation shifts H + \text{H}^+ H + out of cells ( − 2 mEq/L HCO 3 − -2\text{ mEq/L } \text{HCO}_3^- − 2 mEq/L HCO 3 − ​ per 10 mmHg ↓ P CO 2 10\text{ mmHg} \downarrow P_{\text{CO}_2} 10 mmHg ↓ P CO 2 ​ ​ ). Chronic compensation (3–5 days) involves renal reduction in H + \text{H}^+ H + secretion and β \beta β -intercalated HCO 3 − \text{HCO}_3^- HCO 3 − ​ excretion ( − 5 mEq/L HCO 3 − -5\text{ mEq/L } \text{HCO}_3^- − 5 mEq/L HCO 3 − ​ per 10 mmHg ↓ P CO 2 10\text{ mmHg} \downarrow P_{\text{CO}_2} 10 mmHg ↓ P CO 2 ​ ​ ).